Dr. Visco on the Rationale for the MANTLE-FIRST Trial in R/R MCL

preview_player
Показать описание
Carlo Visco, MD, discusses the rationale for the international, retrospective MANTLE-FIRST trial in relapsed/refractory mantle cell lymphoma.

Рекомендации по теме